Deferred Tax Assets, Valuation Allowance of AETHLON MEDICAL INC from 31 Mar 2012 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
AETHLON MEDICAL INC quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Mar 2012 to 31 Mar 2025.
  • AETHLON MEDICAL INC Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Mar 2025 was $34,398,000, a 3.4% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

AETHLON MEDICAL INC Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $34,398,000 +$1,139,000 +3.4% 31 Mar 2025 10-K 26 Jun 2025 2025 FY
Q1 2024 $33,259,000 +$3,237,000 +11% 31 Mar 2024 10-K 26 Jun 2025 2025 FY
Q1 2023 $30,022,000 +$2,932,000 +11% 31 Mar 2023 10-K 27 Jun 2024 2024 FY
Q1 2022 $27,090,000 +$2,328,000 +9.4% 31 Mar 2022 10-K 28 Jun 2023 2023 FY
Q1 2021 $24,762,000 +$1,755,000 +7.6% 31 Mar 2021 10-K 28 Jun 2022 2022 FY
Q1 2020 $23,007,000 +$1,400,000 +6.5% 31 Mar 2020 10-K 24 Jun 2021 2021 FY
Q1 2019 $21,607,000 +$1,333,000 +6.6% 31 Mar 2019 10-K 25 Jun 2020 2020 FY
Q1 2018 $20,274,000 -$5,546,000 -21% 31 Mar 2018 10-K 01 Jul 2019 2018 FY
Q1 2017 $25,820,000 +$2,252,000 +9.6% 31 Mar 2017 10-K 08 Jun 2018 2018 FY
Q1 2016 $23,568,000 +$2,199,000 +10% 31 Mar 2016 10-K 28 Jun 2017 2017 FY
Q1 2015 $21,369,000 +$2,734,000 +15% 31 Mar 2015 10-K 29 Jun 2016 2016 FY
Q1 2014 $18,635,000 +$400,000 +2.2% 31 Mar 2014 10-K 13 Jul 2015 2015 FY
Q1 2013 $18,235,000 +$18,242,245 31 Mar 2013 10-K 15 Jul 2014 2014 FY
Q1 2012 $7,245* 31 Mar 2012 10-K 15 Jul 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.